abstract |
The present disclosure relates to compounds comprising N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide ( Co-crystals of compound 1) and co-formers and methods for their preparation. The present disclosure also relates to pharmaceutical compositions comprising co-crystal forms and methods and kits of treatment utilizing the same. |